0000904454-20-000114.txt : 20200130
0000904454-20-000114.hdr.sgml : 20200130
20200130211104
ACCESSION NUMBER: 0000904454-20-000114
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200128
FILED AS OF DATE: 20200130
DATE AS OF CHANGE: 20200130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: van Deventer Sander
CENTRAL INDEX KEY: 0001543084
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36294
FILM NUMBER: 20563013
MAIL ADDRESS:
STREET 1: POSTBUS 5187
CITY: NAARDEN
STATE: P7
ZIP: 1410 AD
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: uniQure N.V.
CENTRAL INDEX KEY: 0001590560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PAASHEUVELWEG 25A
CITY: AMSTERDAM
STATE: P7
ZIP: 1105 BP
BUSINESS PHONE: 1-339-970-7000
MAIL ADDRESS:
STREET 1: PAASHEUVELWEG 25A
CITY: AMSTERDAM
STATE: P7
ZIP: 1105 BP
FORMER COMPANY:
FORMER CONFORMED NAME: uniQure B.V.
DATE OF NAME CHANGE: 20131030
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-01-28
0001590560
uniQure N.V.
QURE
0001543084
van Deventer Sander
C/O UNIQURE N.V.
PAASHEUVELWEG 25A
AMSTERDAM
P7
11058BP
NETHERLANDS
0
1
0
0
EVP, Research & Product Dev.
Ordinary Shares
2020-01-28
4
S
0
1304
61.27
D
44050
D
Ordinary Shares
2020-01-28
4
S
0
923
62.10
D
43127
D
Ordinary Shares
9859
I
See footnote
As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.85 to $61.83. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares held by Forbion Management. The Reporting Person is a member of Forbion's investment committee, which exercises voting and investment power over such shares. None of the members of the investment committee have individual voting and investment power with respect to such shares, and the Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
The Reporting Person is also a partner of Forbion Capital Partners, which acts as the investment advisor to the directors of ForUniQure B.V. and Forbion 1 Management B.V. (the director of ForUniQure B.V.) with respect to Ordinary Shares held by ForUniQure B.V. The Reporting Person disclaims beneficial ownership of such Ordinary Shares, except to the extent of his proportionate pecuniary interest therein.
/s/ Christian Klemt, Attorney-in-Fact
2020-01-30